Category Archives: Clinical Cardiology

Still taking a daily aspirin to ward off heart attacks? You might want to think again, according to a new review Continue reading →

Rusitanmujiang Maimaitiaili, Jiadela Teliewubai, Song Zhao, Jiamin Tang, Chen Chi, Yi Zhang, Yawei Xu Department of Cardiology, Shanghai Tenth Peoples Hospital, Tongji University School of Medicine, Shanghai, Peoples Republic of China Correspondence: Yi Zhang; Yawei Xu Department of Cardiology, Shanghai Tenth Peoples Hospital, Tongji University School of Medicine, 301 Yanchang Road, Shanghai 200072, Peoples Republic of China Tel/ Fax +86 18917686332 Email yizshcn@gmail.com; xuyawei@tongji.edu.cn Purpose: There have been few recent studies regarding vascular aging and its relationship with left ventricular (LV) geometry. Moreover, the association of abnormal LV geometry with various kinds of vascular aging has not yet been systematically analyzed. Thus, this study aimed to further elucidate this relationship Continue reading →

Contract Pharma (CP): How is COVID-19 impacting the way you meet and exchange ideas with potential clients? David Ng, vice president, biometrics, Wuxi Clinical (DN): The biggest impact is in terms of situations where wed make a larger effort to make a face-to-face visit, i.e. a bid defense meeting Continue reading →

Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Continue reading →

TheGlobal Pediatric Interventional Cardiology Marketaccounted to USD 1.5 billion in 2016 growing at a CAGR of 8.0% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.Some of the major players operating in global pediatric interventional cardiology market are Danaher, Abbott Laboratories, Siemens AG, GENERAL ELECTRIC, Toshiba Corporation, Boston Scientific Corporation, and W.L. Gore & Associates, Inc., Johnson & Johnson Services, Inc., BIOTRONIK, Koninklijke Philips N.V., F Continue reading →

Ultromics, a health-tech company which applies AI to echocardiography, to earlier detect and better diagnose heart disease, has entered a know-how and clinical research agreement with Mayo Clinic. Underpinned by a determination to drive higher standards of patient care, the collaboration will leverage Mayos cardiology expertise and insights and feed real world data into Ultromics first product to market, EchoGo Core. Continue reading →

President Donald Trump made headlines Monday when he voluntarily told reporters that he was taking hydroxychloroquine, which Trump has frequently touted as a game changer for coronavirus. This announcement was the latest development in Trumps weeks-long campaign in support of the drug, despite several reports and studies that have questioned its effectiveness in treating coronavirus patients. Hydroxychloroquine is an anti-malarial drug often used to treat autoimmune diseases like lupus Continue reading →

QUEBEC CITY, May 20, 2020 /CNW Telbec/ -OpSens Inc. ("OpSens"or the "Company") (TSX: OPS)(OTCQX: OPSSF)reached an important milestone with more than 100,000 patients evaluated with the OptoWire, a pressure guidewire for the diagnosis and treatment of coronary artery stenosis. Accuracy in assessing the severity of coronary disease is critical and pressure guidewires have been shown to improve clinical outcomes when used to diagnose coronary disease Continue reading →

May 18, 2020 12:00 ET | Source: Medtronic plc DUBLIN, May 18, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced Jeffrey J. Continue reading →

Patients treated with hydroxychloroquine alone or in combination with azithromycin for pneumonia associated with novel coronavirus disease 2019 (COVID-19) were found to be at increased risk for corrected QT interval (QTc) prolongation, according to study results published in JAMA Cardiology.1 Treatment with hydroxychloroquine or azithromycin has been associated with a risk for prolonged QTc and cardiac dysrhythmias. In this single-center, retrospective, observational cohort study, f 90 patients with COVID-19-associated pneumonia (mean age, 60.116.7 years; 48.9% women; mean body mass index, 31.56.6 kg/m2) who were hospitalized at an academic medical center in Boston, Massachusetts between March 1 and April 7, 2020. Patients in this cohort were treated with hydroxychloroquine for 1 day, with or without azithromycin and had 1 positive COVID-19 polymerase chain reaction test result using nasopharyngeal swabbing. Continue reading →